UK Life Sciences Cautiously Upbeat For Investment Year Ahead – BioWales 2024

Kadans Sciences Investor Panel Offers Pragmatic View Of Market Outlook

Favorable UK biopharma investment trends have been reported by the BioIndustry Association, but can medtech and healthtech share in the positivity? A roundtable at the BioWales in London 2024 event framed the outlook for non-pharma players.

innovation
• Source: Alamy

More from Deal-Making

More from In Vivo